The five-time Grand Slam champion has served 22 days of a one-month ban from tennis. Here's what you need to know

Iga Swiatek has made another change to her staff as she is parting ways with long-time PR manager Paula Wolecka and filling in that spot with Daria Sulgostowska. For the Polish tennis superstar, this is a second team change she has made over the last few months.

World number two Iga Swiatek has accepted a one-month suspension after testing positive for the prohibited substance trimetazidine (TMZ).

Iga Swiatek, the women’s world No. 2 tennis player, has received a one-month doping ban after testing positive for the banned substance trimetazidine (TMZ).

The womens tennis association stands by the Polish player, after the doping issue and the one-month suspension

Iga Swiatek received a one-month ban after positive drug test and will be eligible to play in the Australian Open.

Swiatek said she couldn't play over the fall owing to 'personal matters'. That didn't really explain what was going on

Iga Swiatek, the world No 2 and French Open champion, has accepted a one-month ban after testing positive for trimetazidine (TMZ), a banned substance.

The results for unspecified substances resulted in a mandatory provisional suspension, imposed on September 12th. This resulted in the Pole having to miss the WTA 500 in Korea (September 16-22), the WTA 1000 in Beijing (September 25-October 6) and the WTA 1000 in Wuhan (October 7-13).

Meanwhile, Swiatek was found to have been “at the lowest end of the range for no significant fault or negligence” after the 23-year-old Polish player explained that her doping violation was caused by a contaminated supply of the non-prescription medication melatonin, which she uses to help with jet lag and sleep issues.

Iga Swiatek is the second high-profile tennis player to test positive for a banned substance this year, joining Jannik Sinner. While Sinner, currently the No. 1 ranked man, was fully cleared, Swiatek,